International Clinical Trial: Routine Shallow-coverage Whole Genome Sequencing Testing of Liquid-based Cervical Smears for the Early Diagnosis of Ovarian Cancer

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07821879) titled 'Routine Shallow-coverage Whole Genome Sequencing Testing of Liquid-based Cervical Smears for the Early Diagnosis of Ovarian Cancer' on Sept. 8.

Study Type: Observational

Primary Sponsor: Institut Claudius Regaud

Condition: High Grade Serous Ovarian Cancer Cervical Cancer Screening Whole Genome Sequencing Genomic Instability

Recruitment Status: Recruiting

Date of First Enrollment: January 5, 2025

Target Sample Size: 50

Countries of Recruitment: France

To know more, visit https://clinicaltrials.gov/study/NCT07821879

Published by HT Digital Content Services with permission from Health Daily Digest....